Pluristem Therapeutics Inc. carries a market capitalization of 40.85M, placing it among publicly traded companies globally.
| Market Cap | 40.85M |
| Enterprise Value | N/A |
Pluristem Therapeutics Inc.'s stock has declined approximately -39.75904% over the past 52 weeks.
| Beta (5Y) | N/A |
| 52-Week Price Change | -39.75904% |
| 50-Day Moving Average | N/A |
| 200-Day Moving Average | N/A |
| Average Volume (20 Days) | N/A |
Pluristem Therapeutics Inc.'s most recent stock split took place on July 25, 2019 with a 10:1 split ratio.
| Last Split Date | 7/25/2019 |
| Split Ratio | 10:1 |